AGMB-102

N/A

Report date: 2023/05/22 10:19:24

Base Information

Drug NameAGMB-102
Drug Alias NameAGMB-102
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionHepatocyte growth factor receptor agonists
TargetsHepatocyte growth factor receptor
Therapy Area/IndicationsFibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgium
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAgomAb Therapeutics NV
China Registration ClassN/A

Develop Information

Active CompaniesAgomAb Therapeutics NV
Inactive CompaniesN/A
Active IndicationsFibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A